Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

InMed Pharmaceuticals Inc. - Common Shares (NQ:INM)

1.250 +0.020 (+1.63%)
Streaming Delayed Price Updated: 4:00 PM EST, Nov 20, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about InMed Pharmaceuticals Inc. - Common Shares

< Previous 1 2 3 4 5 6 7 8 9
...
14 15 Next >
News headline image
Why Is InMed (INM) Stock Up 110% Today? ↗
Here's what investors in INM stock may want to watch, given the company's recent impressive early results from an Alzheimer's drug candidate. 
Via InvestorPlace
News headline image
Nasdaq Gains 100 Points; Coca-Cola Earnings Top Expectations ↗
U.S. stocks traded higher toward the end of trading, with the Dow Jones index gaining over 200 points on Tuesday. The Dow traded up 0.67% to 33,155.68 while the NASDAQ rose 0.78% to 13,120.31. The S&P... 
Via Benzinga
Topics Stocks
News headline image
Why Asbury Automotive Group Shares Are Trading Lower By Over 6%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session ↗
Gainers InMed Pharmaceuticals Inc. (NASDAQ: INM) shares climbed 169% to $1.56 after the company announced it selected a lead Alzheimer's drug candidate following proof-of-concept study data. 
Via Benzinga
News headline image
Crude Oil Down Over 2%; General Motors Posts Upbeat Earnings ↗
U.S. stocks traded slightly higher midway through trading, with the Dow Jones index gaining around 50 points on Tuesday. The Dow traded up 0.17% to 32,992.95 while the NASDAQ rose 0.06% to 13,023.65.... 
Via Benzinga
Topics Stocks
BioMedNewsBreaks – InMed Pharmaceuticals Inc. (NASDAQ: INM) to Advance INM-901 Following Positive Proof-of-Concept Results
Via Investor Brand Network
News headline image
Why InMed Pharmaceuticals Stock Is Soaring Tuesday ↗
InMed Pharmaceuticals Inc (NASDAQ: INM) shares are trading higher Tuesday after the company said it selected a lead Alzheimer's drug candidate following positive proof-of-concept study data.  
Via Benzinga
News headline image
Dow Surges 250 Points; US Manufacturing PMI Tops Expectations ↗
U.S. stocks traded higher this morning, with the Dow Jones index gaining over 250 points on Tuesday. Following the market opening Tuesday, the Dow traded up 0.80% to 33,200.75 while the NASDAQ rose... 
Via Benzinga
Topics Stocks
News headline image
InMed Pharmaceuticals, A Cannabinoid-Focused Company, Sponsored Benzinga's Cannabis Capital Conference ↗
InMed Pharmaceuticals (NASDAQ: INM) is a global leader in researching, developing, manufacturing and commercializing rare cannabinoids and cannabinoid analogs. 
Via Benzinga
Topics Cannabis
News headline image
Cannabis Industry Report Highlights Positive Sentiment and Growth Potential at Benzinga Conference ↗
Discover key insights from the Benzinga Cannabis Conference, featuring strategies from top firms like MariMed, AYR & InMed! 
Via Benzinga
Topics Cannabis
BioMedNewsBreaks – InMed Pharmaceuticals Inc. (NASDAQ: INM) Releases FY 2023 Report, Shares Corporate Update
Via Investor Brand Network
News headline image
This Clinical Stage BioPharma Is Seeing Solid Growth In Rare Cannabinoid Demand From The Health And Wellness Sector ↗
BayMedica, a rare cannabinoids supplier for the health and wellness sector acquired by InMed Pharmaceuticals (NASDAQ: INM) in 2021, is scaling up its manufacturing process to meet growing demand. 
Via Benzinga
Topics Supply Chain
BioMedNewsBreaks – InMed Pharmaceuticals Inc. (NASDAQ: INM) to Present at H.C. Wainwright 25th Annual Global Investment Conference
Via Investor Brand Network
News headline image
Cannabis Stock Gainers And Losers From August 25, 2023 ↗
 
Via Benzinga
Topics Cannabis
News headline image
Marijuana Stock Movers For August 22, 2023 ↗
 
Via Benzinga
Topics Cannabis
News headline image
Cannabis Stock Gainers And Losers From July 25, 2023 ↗
 
Via Benzinga
News headline image
Cannabis Stock Gainers And Losers From August 16, 2023 ↗
 
Via Benzinga
Topics Cannabis
News headline image
Cannabis Stock Movers For July 21, 2023 ↗
 
Via Benzinga
News headline image
Marijuana Stock Movers For August 15, 2023 ↗
 
Via Benzinga
Topics Cannabis
CannabisNewsBreaks – InMed Pharmaceuticals Inc. (NASDAQ: INM) Announces Participation in Water Tower Research Fireside Chat Series
Via CannabisNewsWire
Topics Supply Chain
News headline image
Cannabis Stock Gainers And Losers From August 11, 2023 ↗
 
Via Benzinga
Topics Cannabis
CannabisNewsBreaks – InMed Pharmaceuticals Inc. (NASDAQ: INM) Announces Participation in Water Tower Research Fireside Chat Series
Via Investor Brand Network
Topics Supply Chain
News headline image
Cannabis Stock Movers For August 10, 2023 ↗
 
Via Benzinga
Topics Cannabis
CannabisNewsBreaks – InMed Pharmaceuticals Inc. (NASDAQ: INM) Issues Update on BayMedica Rare Cannabinoid Business
Via CannabisNewsWire
Topics Supply Chain
News headline image
Marijuana Stock Movers For August 8, 2023 ↗
 
Via Benzinga
CannabisNewsBreaks – InMed Pharmaceuticals Inc. (NASDAQ: INM) Issues Update on BayMedica Rare Cannabinoid Business
Via Investor Brand Network
Topics Supply Chain
News headline image
Marijuana Stock Movers For August 1, 2023 ↗
 
Via Benzinga
News headline image
Game-Changer In Epidermolysis Bullosa Treatment? Cannabis Compound Holds Promise ↗
In a positive step for the treatment of the rare genetic dermatological condition known as epidermolysis bullosa (EB), InMed Pharmaceuticals Inc. (NASDAQ: INM) has published top-line data from its... 
Via Benzinga
News headline image
Cannabis Stock Movers For July 24, 2023 ↗
 
Via Benzinga
News headline image
Cannabis Stock Movers For July 20, 2023 ↗
 
Via Benzinga
News headline image
Why Avid Bioservices Shares Are Trading Lower By Over 14%? Here Are Other Stocks Moving In Thursday's Mid-Day Session ↗
Gainers Aeglea BioTherapeutics, Inc. (NASDAQ: AGLE) shares climbed 422% to $0.5572 after the company announced acquisition of Spyre Therapeutics and concurrent oversubscribed $210 million private... 
Via Benzinga
< Previous 1 2 3 4 5 6 7 8 9
...
14 15 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.